Cd3 antibody biolegend il6
Por um escritor misterioso
Descrição
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
CD3 engagement as a new strategy for allogeneic “off-the-shelf” T cell therapy: Molecular Therapy - Oncolytics
Experimental venous thrombus resolution is driven by IL-6 mediated monocyte actions
High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma - ScienceDirect
Cells, Free Full-Text
IL6 suppresses vaccine responses in neonates by enhancing IL2 activity on T follicular helper cells
Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL
TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity
Activation of CD8 T cells accelerates anti-PD-1 antibody-induced psoriasis-like dermatitis through IL-6
de
por adulto (o preço varia de acordo com o tamanho do grupo)